NeuroTalk Support Groups - MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Am

NeuroTalk Support Groups (https://www.neurotalk.org/)

- ALS News & Research (https://www.neurotalk.org/als-news-and-research/)

- - MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Am (https://www.neurotalk.org/als-news-and-research/240910-medicinova-announces-fda-granted-orphan-drug-designation-mn-166-ibudilast-am.html)

MuonOne

10-12-2016 11:15 AM

MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Am

MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis

MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis - EconoTimes

All times are GMT -5. The time now is 06:26 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.